Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acoustic neurinoma
acoustic neurinoma, bilateral
acquired immunodeficiency syndrome
adrenoleukodystrophy
advances in neurology
adverse drug reaction
Alexanders disease
algorithm
Alzheimer's disease
Alzheimer's disease, familial
amniocentesis
amyloid angiopathy, cerebral
amyloid angiopathy, hereditary cystatin C
attention deficit disorder with hyperactivity
audiogram
auditory evoked brainstem potentials
basal ganglia, degeneration
basal ganglia, lesion of
Bassen-Kornzweig syndrome
brain biopsy
brainstem, lesion of
bulbar palsy, progressive
calcification, intracranial
CAT scan, emission
CAT scan, emission, abnormal
cataracts
cerebellar lesion
cerebro hepato renal syndrome
cerebrovascular accident
cerebrovascular accident, familial occurrence
cerebrovascular accident, young adult
Charcot-Marie-Tooth
children
chromosomal abnormality
chromosome 17
chromosome 22
chromosome 9
Cockayne's syndrome
cost effectiveness
creatine phosphokinase(CPK)elevated
cryptococcal meningitis
cytomegalovirus infection
dentate nuclei
dentate nuclei, lesion of
DNA probes
drug induced neurologic disorders
dystonia
dystonia musculorum deformens
dystrophin
ear, abnormal
electronystagmography
electroretinograph
encephalitis
encephalitis, focal
encephalitis, Rasmussen's
encephalitis, viral
enzyme, muscle disease
ependymoma
face, elongated
facial appearance, abnormal
familial
fasciculation
fragile-X syndrome
fundus, abnormality of
gadolinium
gene
gene mutation
genetic counselling
genetic diagnosis, prenatal
genetic linkage
genetic neurologic disorders
genetic screening
genetic testing
gynecomastia
Hallervorden Spatz disease
hearing loss
hemiparesis
hepatolenticular degeneration(Wilson's disease)
Huntington's chorea
Huntington's chorea, genetic counselling
Huntington's chorea, late onset
Huntington's chorea, presymptomatic detection of
Huntington's disease, children
hyperactivity
imbalance
immunohistochemistry
immunoperoxidase staining
in situ hybridization
inclusion bodies, intracytopasmic
intracerebral hemorrhage
intracerebral hemorrhage, familial
intracerebral hemorrhage, young adult
joint hypermobility
Kearns-Sayre syndrome
Kugelberg-Welander syndrome
Laurence-Moon-Bardet-Biedl syndrome
leukodystrophy
leukoencephalopathy
macular degeneration
manic-depressive
meningioma
meningitis
meningitis, recurrent
meningitis, relapse
mental retardation
mental retardation, familial
misdiagnosis
molecular genetics
mongolism
motor neuron disease
MRI
MRI, abnormal
MRI, contrast enhanced
mucopolysaccharidoses
muscle biopsy
muscular dystrophy
muscular dystrophy, Becker
muscular dystrophy, differential diagnosis of
muscular dystrophy, Duchenne
muscular dystrophy, Duchenne, carrier
muscular dystrophy, Duchenne, neonatal screening
muscular dystrophy, Duchenne, presymptomatic detection
muscular dystrophy, female occurrence of
muscular dystrophy, limb-girdle
myopathy, mitochondrial
myopia
myotonia dystrophica
neonatal screening, genetic neurologic disorders
neoplasm, intracranial
neoplasm, intracranial, multiple
neoplasm, primary of CNS
neoplasm, primary of CNS-multiple
nerve growth factor
neurofibromatosis 1
neurofibromatosis 2
neurofibromatosis 2, presymptomatic
neurologic disease
neurologic disease, diagnoses of
neuronal ceroid-lipofuscinosis
neuropathology
neuropathy
neuropathy, amyloid
neuropathy, hereditary peripheral
neuropathy, peripheral
neurotransmitter
night blindness
optic atrophy
optic nerve
optic neuropathy
patient information and support
peptides, brain
peroxisomal disease
pigmentary retinopathy
polymerase chain reaction
polyneuropathy, familial
posterior fossa, lesion of
pregnancy, neurologic complications in
prenatal diagnosis by amniocentesis
prognosis
progressive multifocal leucoencephalopathy
progressive spinal muscular atrophy
psychological testing
psychological testing, neurologic problems
recombinant DNA
recurrent
refractive errors
Refsum's disease
retinal degeneration
retinal lesion
retinitis pigmentosa
retinopathy
review article
RFLPs
Rosenthal fibers
seizure
seizure, focal
seizure, intractable, treatment of
sensorineural hearing loss
simian crease
somatostatin
Southern immunoblot test
spinal muscular atrophy
spinocerebellar degeneration
tapetoretinal degeneration
testicular enlargement
tinnitus
treatment of neurologic disorder
Usher's syndrome
viral infection
viral infection, CNS
visual field defect
visual loss
visuospatial disturbance
Von Hippel Lindau
Von Hippel Lindau, carrier
Von Hippel Lindau, screening protocol for
Western immunoblot test
white matter disease
Wood's light
X-linked bulbospinal neuronopathy
X-linked neuropathy
Showing articles 600 to 650 of 885 << Previous Next >>

rtPA Intravenous Thrombolysis in Anterior Choroidal Artery Territory Stroke
Neurol 54:666-673, Trouillas,P.,et al, 2000

Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Patients Aged 80 Years and Older, The tPa Stroke Survey Experience
Stroke 31:370-375, Tanne,D.,et al, 2000

Treating Acute Stroke Patients with Intravenous tPA, The OSF Stroke Network Experience
Stroke 31:77-81, Wang,D.Z.,et al, 2000

Cerebral Venous Thrombosis Associated with Epoetin Alfa Therapy
Arch Neurol 57:260-262, Finelli,P.F.&Carley,M.D., 2000

Stroke Treatment with Tissue Plasminogen Activator in the Setting of Aortic Dissection
Neurol 54:1010, Fessler,A.J. & Alberts,M.J., 2000

Neurological Emergencies: Acute Stroke
JNNP 68:277-288, Davenport,R. & Dennis,M., 2000

Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke
JAMA 283:1145-1150,1189, Albers,G.W.,et al, 2000

Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
JAMA 283:1151-1158,1189, Katzan,I.L.,et al, 2000

Intravenous tPA in Acute Ischemic Stroke Related to Internal Carotid Artery Dissection
Neurol 54:2159-2161, Derex,L.,et al, 2000

Endovascular Treatment of Dural Sinus Thrombosis With Rheolytic Thrombectomy and Intra-Arterial Thrombolysis
Stroke 31:1420-1425, Chow,K.,et al, 2000

Monitoring Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis for Acute Ischemic Stroke With Diffusion and Perfusion MRI
Stroke 31:1318-1328, Schellinger,P.D.,et al, 2000

Validity and Reliability of a Quantitative Computed Tomography Score in Predicting Outcome of Hyperacute Stroke Before Thrombolytic Therapy
Lancet 355:1670-1674, Barber,P.A.,et al, 2000

Intravenous Ancrod for Treatment of Acute ischemic Stroke
JAMA 283:2395-2403, Sherman,D.G.,et al, 2000

Ancrod-Is Snake Venom an Antidote for Stroke
JAMA 283:2440-2441, Mayberg,M.R.&Furlan,A., 2000

Transcranial Doppler Ultrasound Criteria for Recanalization After Thrombolysis for Middle Cerebral Artery Stroke
Stroke 31:1128-1132, Burgin,W.S.,et al, 2000

Comparison of Diffusion-Weighted MRI and CT in Acute Stroke
Neurol 54:1557-1561,1548,1549,1552, Lansberg,M.G.,et al, 2000

Treatment of Intraventricular Hemorrhage with Urokinase
Stroke 31:841-847, Naff,N.J.,et al, 2000

Stereotactic Computed Tomographic-Guided Aspiration and Thrombolysis of Intracerebral Hematoma
Stroke 31:834-840, Montes,J.M.,et al, 2000

Thrombolytic Reversal of Acute Human Cerebral Ischemic Injury Shown by Diffusion/Perfusion Magnetic Resonance imaging
Ann Neurol 47:462-469, Kidwell,C.S.,et al, 2000

Stroke Mimicry: Four Cases Eligible for Tissue Plasminogen Activator
The Neurologist 6:220-223, Kirshner, H.S., 2000

Intracranial Hemorrhage Associated With Thrombolytic Therapy for Eldery Patients With Acute Myocardial Infarction
Stroke 31:1802-1811, Brass,L.M. et al, 2000

Orolingual Angioneurotic Edema Following Therapy of Acute Ischemic Stroke with Alteplase
Neurol 55:599-600, Rudolf,J. et al, 2000

Treatment of Acute Ischemic Stroke
NEJM 343:710-722, Brott, T. & Bogousslavsky, J., 2000

Combined Intravenous and Intra-Arterial Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
Stroke 31:2552-2557, Ernst,R.,et al, 2000

Thrombolytic Therapy in Patients with Acute Ischemic Stroke
Arch Neurol 57:1430-1436, Hinchey,J.A. & Benesch,C., 2000

Cerebral Venous Thrombosis: Anticoagulants or Thrombolyic Therapy?
JNNP 69:427-430, Benamer,H.T.S. & Bone,I., 2000

Early Stroke Treatment Associated with Better Outcome
Neurol 55:1649-1655, Marler,J.R.,et al, 2000

Effect of intravenous Recombinant Tissue Plasminogen Activator on Ischemic Stroke Lesion Size Measured by Computed Tomography
Stroke 31:2912-2919, The National Institute of Neurological Disorders a, 2000

Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Stroke 31:2920-2924, Chapman,K.M.,et al, 2000

Can Emergency Department Physicians Safely and Effectively Initiate Thrombolysis for Acute Ischemic Stroke?
Neurol 55:1801-1805, Akins,P.T.,et al, 2000

Serum Glucose Level and Diabetes Predict Tissue Plasminogen Activator-Related Intracerebral Hemorrhage in Acute Ischemic Stroke
Stroke 30:34-39, Demchuk,A.M.,et al, 1999

CT Angiography and Doppler Sonography for Emergency Assessment in Acute Basilar Artery Ischemia
Stroke 30:606-612, Brandt,T.,et al, 1999

Diagnosis and Treatment of Ischemic Stroke
Am J Med 106:211-221, Alberts,M.J., 1999

Acute Vertebrobasilar Occlusion:Treatment with High-Dose Intraarterial Urokinase
AJR 172:709-712, Hoffman,A.I.,et al, 1999

Application of a Rheolytic Thrombectomy Device in the Treatment of Dural Sinus Thrombosis:A New Technique
AJNR 20:568-570, Dowd,C.F.,et al, 1999

Evidence of Anaphylaxy after Alteplase Infusion
Stroke 30:1142-1143, Rudolf,J.,et al, 1999

Superselective Intraarterial Fibrinolysis in Central Retinal Artery Occlusion
AJNR 20:565-567, Padolecchia,R.,et al, 1999

Association of Hyperdense Middle Cerebral Artery Sign with Clinical Outcome in Patients Treated with Tissue Plasminogen Activator
Stroke 30:769-772, Manelfe,C.,et al, 1999

Evaluation of Early Reperfusion and IV tPA Therapy Using Diffuion- and Perfusion-Weighted MRI
Neurol 52:1792-1798,1733, Marks,M.P.,et al, 1999

Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
NEJM 340:1781-1787, Kwiatkowski,T.G.,et al, 1999

Familial Paroxysmal Dystonic Choreoathetosis,Clinical Findings in a Large Japanese Family and Genetic Linkage to 2q
Arch Neurol 56:721-726, Matsuo,H.,et al, 1999

Applications of Diffusion-Perfusion Magnetic Resonance Imaging in Acute Ischemic Stroke
Neurol 52:1750-1756,1733, Fisher,M.&Albers,G.W., 1999

Initial Clinical Experience with IV Tissue Plasminogen Activator for Acute Ischemic Stroke:A Multicenter Survey
Neurol 53:424-427, Tanne,D.,et al, 1999

Consent Issues in the Management of Cerebrovascular Diseases, A Position Paper of the American Academy of Neurology Ethics and Humanities Subcommittee
Neurol 53:9-11, , 1999

Intraarterial Thrombolysis for Treatment of Acute Stroke:Experience in 26 Patients with Long-Term Follow-Up
AJNR 20:1291-1299, 1194, Jahan,R.,et al, 1999

Agreement and Variability in the Interpretation of Early CT Changes in Stroke Patients Qualifying for Intravenous rtPA Therapy
Stroke 30:1528-1533, Grotta,J.C.,et al, 1999

Intra-Arterial Cerebral Thrombolysis for Acutre Ischemic Stroke in a Community Hospital
AJNR 20:1682-1687,1580, Edwards,M.T.,et al, 1999

Predictors of Clinical Improvement,Angiographic Recanalization, and Intracranial Hemorrhage After Intra-Arterial Thrombolysis for Acute Ischemic Stroke
Stroke 30:2094-2100, Suarez,J.I.,et al, 1999

Expanding the Window for Thrombolytic Therapy in Acute Stroke, The Potential Role of Acute MRI for Patient Selection
Stroke 30:2230-2237, Albers,G.W., 1999

MRI Features of Intracerebral Hemorrhage Within 2 Hours from Symptom Onset
Stroke 30:2263-2267, Linfante,I.,et al, 1999



Showing articles 600 to 650 of 885 << Previous Next >>